J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 2,188.80
-37.65 (-1.69%)
At close: May 26, 2026
BOM:506943 Market Cap
BOM:506943 has a market cap or net worth of 353.57 billion as of May 27, 2026. Its market cap has increased by 47.75% in one year.
Market Cap
353.57B
Enterprise Value
344.76B
Revenue
42.08B
Ranking
n/a
PE Ratio
49.54
Stock Price
2,188.80
Market Cap Chart
Since December 11, 2001, BOM:506943's market cap has increased from 408.70M to 353.57B, an increase of 86,411.66%. That is a compound annual growth rate of 31.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 351.43B | 23.23% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.09T |
| Lupin | 1.04T |
| Abbott India | 591.22B |
| GlaxoSmithKline Pharmaceuticals | 391.29B |
| AstraZeneca Pharma India | 215.11B |
| Granules India | 186.24B |
| Jubilant Pharmova | 159.31B |
| Rubicon Research | 156.47B |